You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ethionamide

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB) Trial in Cape Town (BVL-GSK098 9mg, Ethionamide 250mg,

Not yet recruiting
  • Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)
  • BVL-GSK098 9mg
  • +3 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
Jul 26, 2022

Ethionamide and Ethionamide Sulfoxide in Patients Established on

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Plasma samples
  • Cape Town, South Africa
    TASK Applied Sciences
Feb 17, 2022

Frontotemporal Dementia Trial (ET-STEM)

Not yet recruiting
  • Frontotemporal Dementia
  • (no location specified)
May 11, 2022

TB-CAPT MTB/XDR Study

Recruiting
  • Tuberculosis
  • +2 more
  • Xpert MTB/XDR
  • Cape Town, South Africa
  • +1 more
May 17, 2021

HIV, Tuberculosis Trial in United States (Cycloserine, Ethionamide, Capreomycin sulfate)

Completed
  • HIV Infections
  • Tuberculosis
  • Chicago, Illinois
  • +20 more
Oct 27, 2021

Osteomyelitis Trial in Louisville (oral antibiotics, intravenous antibiotics)

Terminated
  • Osteomyelitis
  • oral antibiotics
  • intravenous antibiotics
  • Louisville, Kentucky
    University of Louisville
Apr 2, 2021

Pharmacometric Optimization of Second Line Drugs for MDR

Completed
  • Multidrug-resistant Tuberculosis
    • Cape Town, Western Cape, South Africa
    • +1 more
    Apr 28, 2021

    Antiretroviral Drugs and Related Drugs During and After

    Completed
    Has Results
    • HIV Infections
    • Birmingham, Alabama
    • +61 more
    Jun 28, 2022

    Tuberculosis Trial in Worldwide (FLOW-TB Next-generation LAM, TAM-TB, Host Response Cartridge)

    Recruiting
    • Tuberculosis
    • FLOW-TB Next-generation LAM
    • +13 more
    • Vellore, India
    • +10 more
    Dec 8, 2022

    Triage Test for All Oral DR-TB Regimen (TRiAD Study)

    Recruiting
    • Drug Resistant Tuberculosis
    • +3 more
    • Xpert® MTB/XDR
    • Gulele, Addis Ababa, Ethiopia
    • +3 more
    Jun 13, 2022

    Tuberculosis, Multidrug-Resistant Trial in Cape Town (Targeted sequencing using the GenoScreen Deeplex assay)

    Not yet recruiting
    • Tuberculosis, Multidrug-Resistant
    • Targeted sequencing using the GenoScreen Deeplex assay
    • Cape Town, Western Cape, South Africa
      University of Cape Town
    Sep 28, 2021

    Cardiovascular Diseases, Coronary Disease, Heart Diseases Trial (aspirin, carotene)

    Completed
    • Cardiovascular Diseases
    • +3 more
    • (no location specified)
    Jan 26, 2021

    Tuberculosis, Multidrug-Resistant Trial in Kiyose, Sakai (TMC207 (bedaquiline), Background Regimen (BR))

    Completed
    • Tuberculosis, Multidrug-Resistant
    • TMC207 (bedaquiline)
    • Background Regimen (BR)
    • Kiyose, Japan
    • +1 more
    Oct 30, 2019

    Salivary Therapeutic Drug Monitoring of Anti-Tuberculosis Drugs

    Completed
    • Tuberculosis
    • Saliva sampling
    • Plasma/serum sampling
    • Haren, Groningen, Netherlands
      University Medical Center Groningen (UMCG) Beatrixoord
    Nov 20, 2018

    Tuberculosis, Pulmonary, Antibiotic Prophylaxis Trial in Dourados (Isoniazid 900 milligrams, Placebo)

    Terminated
    Has Results
    • Tuberculosis, Pulmonary
    • Antibiotic Prophylaxis
    • Isoniazid 900 milligrams
    • Placebo
    • Dourados, Mato Grosso Do Sul, Brazil
      Roberto Oliveira
    Oct 2, 2019

    Tuberculosis Multi Drug Resistant Active Trial (Delamanid, Linezolid, Levofloxacin)

    Withdrawn
    • Tuberculosis Multi Drug Resistant Active
    • (no location specified)
    Sep 7, 2017